Continuous sonication method for preparing protein encapsulated microbubbles

• US 4,957,656 A
• Filed: 09/14/1988
• Issued: 09/18/1990
• Est. Priority Date: 09/14/1988
• Status: Expired due to Term

• Current Assignee: Molecular Biosystems Incorporated San Diego CA
• Original Assignee: Molecular Biosystems, Inc (Alliance Pharmaceutical Corporation)
• Inventors: Cerny, David, Westkaemper, Peter J., Mills, Gary J.
• Primary Examiner(s): Lovering, Richard D.
• Assistant Examiner(s): Metzmaier, Daniel S.
• Application Number:
  US07/244,844
• Time in Patent Office: 734 Days
• Field of Search: 252/307, 128/662.02, 106/122
• US Class Current: 424/9.52
• CPC Class Codes: A61K 49/223 Microbubbles, hollow microspheres, free gas bubbles, gas microspheres

Abstract

An ultrasonic imaging agent is produced by a continuous sonication processing of an aqueous solution of heat-denaturable biocompatible protein. The solution is carefully preheated to a temperature of incipient protein denaturation without forming insolubilized protein. A gaseous fluid, preferably air, is added to the solution. In the sonication, the air-containing solution is foamed, increasing the formation and concentration of microbubbles, and the solution is further heated to insolubilize a portion of the protein, thereby encapsulating the microbubbles and forming particulate microspheres.

Claims

1. The method of producing an imaging agent for diagnostic use in the human circulatory system in which an aqueous solution of human serum albumin in subjected to sonication to form minute gas-center microspheres, wherein the improvement comprises:

(a) prior to sonication rapidly heating an aqueous solution of human serum albumin to a temperature of incipient denaturation of albumin;

(b) dispersing a biocompatible gas in said heated solution;

(c) flowing the gas-containing heated solution through a chamber enclosing an operating sonicator which provides a stationary horn immersed in the solution as it passes through said chamber; and

(d) with a solution residence time in said chamber of from 1 to 20 seconds forming microspheres of less than 10 microns diameter at concentrations in excess of 40×

10⁶ microspheres per milliliter of solution, the stability of said microspheres being such that said solution maintains said excess concentration for over 8 weeks at 20°

to 25°

C.

2. The method of claim 1 in which the solution subjected to said sonication has an albumin concentration of from 0.5 to 7.5 percent by weight.

3. The method of claim 1 in which the solution subjected to sonication has an albumin concentration of around 5 percent by weight.

4. The method of producing an imaging agent for diagnostic use in the human circulatory system in which an aqueous solution of human serum albumin is subjected to sonication to form minute air-center microspheres, wherein the improvement comprises:

(a) prior to sonication rapidly heating an aqueous solution of human serum albumin to a temperature in the range from 70°

to 75°

C. without denaturing the albumin, said solution having an albumin concentration of from 0.5 to 7.5 percent by weight;

(b) dispersing air in said heated solution;

(c) flowing the air-containing heated solution through a chamber enclosing an operating sonicator which provides a stationary horn immersed in the solution as it passes through said chamber; and

(d) with a solution residence time in said chamber of from 1 to 20 seconds forming microspheres predominately sized in the range from 3 to 8 microns diameter, said microspheres being formed at concentrations in excess of 40×

10⁶ microspheres per milliliter of solution, the stability of said microspheres being such that said solution maintains said excess concentration for over 8 weeks at 20°

to 25°

C.

5. The method of claim 4 in which said solution has an albumin concentration around 5% by weight, and said heating in step (a) is to a temperature of approximately 74°

C.

6. The method of claim 4 and 5 in which said microspheres as produced in steps (c) and (d) have means diameters in a range from 4 to 6 microns, and the microspherecontaining solution has a concentration in excess of 400×

10⁶ microspheres per milliliter.